182 related articles for article (PubMed ID: 22561017)
1. Blocking FSH action attenuates osteoclastogenesis.
Zhu LL; Tourkova I; Yuen T; Robinson LJ; Bian Z; Zaidi M; Blair HC
Biochem Biophys Res Commun; 2012 May; 422(1):54-8. PubMed ID: 22561017
[TBL] [Abstract][Full Text] [Related]
2. Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis.
Zhu LL; Blair H; Cao J; Yuen T; Latif R; Guo L; Tourkova IL; Li J; Davies TF; Sun L; Bian Z; Rosen C; Zallone A; New MI; Zaidi M
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14574-9. PubMed ID: 22908268
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning of the mouse follicle-stimulating hormone receptor complementary deoxyribonucleic acid: functional expression of alternatively spliced variants and receptor inactivation by a C566T transition in exon 7 of the coding sequence.
Tena-Sempere M; Manna PR; Huhtaniemi I
Biol Reprod; 1999 Jun; 60(6):1515-27. PubMed ID: 10330114
[TBL] [Abstract][Full Text] [Related]
4. Follicle-stimulating hormone does not impact male bone mass in vivo or human male osteoclasts in vitro.
Ritter V; Thuering B; Saint Mezard P; Luong-Nguyen NH; Seltenmeyer Y; Junker U; Fournier B; Susa M; Morvan F
Calcif Tissue Int; 2008 May; 82(5):383-91. PubMed ID: 18465073
[TBL] [Abstract][Full Text] [Related]
5. FSH directly regulates bone mass.
Sun L; Peng Y; Sharrow AC; Iqbal J; Zhang Z; Papachristou DJ; Zaidi S; Zhu LL; Yaroslavskiy BB; Zhou H; Zallone A; Sairam MR; Kumar TR; Bo W; Braun J; Cardoso-Landa L; Schaffler MB; Moonga BS; Blair HC; Zaidi M
Cell; 2006 Apr; 125(2):247-60. PubMed ID: 16630814
[TBL] [Abstract][Full Text] [Related]
6. Further evidence for direct pro-resorptive actions of FSH.
Sun L; Zhang Z; Zhu LL; Peng Y; Liu X; Li J; Agrawal M; Robinson LJ; Iqbal J; Blair HC; Zaidi M
Biochem Biophys Res Commun; 2010 Mar; 394(1):6-11. PubMed ID: 20171951
[TBL] [Abstract][Full Text] [Related]
7. A role of insulin-like growth factor I for follicle-stimulating hormone receptor expression in rat granulosa cells.
Minegishi T; Hirakawa T; Kishi H; Abe K; Abe Y; Mizutani T; Miyamoto K
Biol Reprod; 2000 Feb; 62(2):325-33. PubMed ID: 10642569
[TBL] [Abstract][Full Text] [Related]
8. Loss of alternately spliced messenger RNA of the luteinizing hormone receptor and stability of the follicle-stimulating hormone receptor messenger RNA in granulosa cell tumors of the human ovary.
Reinholz MM; Zschunke MA; Roche PC
Gynecol Oncol; 2000 Nov; 79(2):264-71. PubMed ID: 11063655
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of follicle-stimulating hormone (FSH)-receptor messenger RNA levels in the hamster ovary: effect of the endogenous and exogenous FSH.
Zhang YM; Roy SK
Biol Reprod; 2004 Jun; 70(6):1580-8. PubMed ID: 14749302
[TBL] [Abstract][Full Text] [Related]
10. Genetic variations altering FSH action affect circulating hormone levels as well as follicle growth in healthy peripubertal girls.
Busch AS; Hagen CP; Almstrup K; Main KM; Juul A
Hum Reprod; 2016 Apr; 31(4):897-904. PubMed ID: 26905078
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning, sequence analysis and expression of the snake follicle-stimulating hormone receptor.
Bluhm AP; Toledo RA; Mesquita FM; Pimenta MT; Fernandes FM; Ribela MT; Lazari MF
Gen Comp Endocrinol; 2004 Jul; 137(3):300-11. PubMed ID: 15201068
[TBL] [Abstract][Full Text] [Related]
12. Follicle-stimulating hormone receptor mRNA in the mouse ovary during post-natal development in the normal mouse and in the adult hypogonadal (hpg) mouse: structure of alternate transcripts.
O'Shaughnessy PJ; Marsh P; Dudley K
Mol Cell Endocrinol; 1994 May; 101(1-2):197-201. PubMed ID: 9397953
[TBL] [Abstract][Full Text] [Related]
13. Regulation of FSH receptor promoter activation in the osteoclast.
Zaidi S; Zhu LL; Mali R; Iqbal J; Yang G; Zaidi M; Sun L
Biochem Biophys Res Commun; 2007 Oct; 361(4):910-5. PubMed ID: 17681281
[TBL] [Abstract][Full Text] [Related]
14. The Relationship between Follicle-stimulating Hormone and Bone Health: Alternative Explanation for Bone Loss beyond Oestrogen?
Chin KY
Int J Med Sci; 2018; 15(12):1373-1383. PubMed ID: 30275766
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
16. Hormone-induced receptor gene splicing: enhanced expression of the growth factor type I follicle-stimulating hormone receptor motif in the developing mouse ovary as a new paradigm in growth regulation.
Babu PS; Danilovich N; Sairam MR
Endocrinology; 2001 Jan; 142(1):381-9. PubMed ID: 11145601
[TBL] [Abstract][Full Text] [Related]
17. Epitope-specific monoclonal antibodies to FSHβ increase bone mass.
Ji Y; Liu P; Yuen T; Haider S; He J; Romero R; Chen H; Bloch M; Kim SM; Lizneva D; Munshi L; Zhou C; Lu P; Iqbal J; Cheng Z; New MI; Hsueh AJ; Bian Z; Rosen CJ; Sun L; Zaidi M
Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2192-2197. PubMed ID: 29440419
[TBL] [Abstract][Full Text] [Related]
18. Antisense oligodeoxynucleotide inhibits expression of recombinant porcine follicle-stimulating hormone receptor.
Zhu C; Wang Y; Nixon MD; La Barbera AR
Mol Reprod Dev; 2003 Jun; 65(2):188-93. PubMed ID: 12704730
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of desensitization of follicle-stimulating hormone (FSH) action in a murine granulosa cell line stably transfected with the human FSH receptor complementary deoxyribonucleic acid.
Manna PR; Pakarainen P; Rannikko AS; Huhtaniemi IT
Mol Cell Endocrinol; 1998 Nov; 146(1-2):163-76. PubMed ID: 10022774
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing converts the G-protein coupled follitropin receptor gene into a growth factor type I receptor: implications for pleiotropic actions of the hormone.
Sairam MR; Jiang LG; Yarney TA; Khan H
Mol Reprod Dev; 1997 Dec; 48(4):471-9. PubMed ID: 9364441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
